![](https://endpts.com/wp-content/uploads/2024/07/Biovectra-manufacturing-feature.jpg)
A Biovectra manufacturing facility (Photo: Business Wire)
Agilent Technologies to acquire CDMO Biovectra for $925M
Agilent Technologies plans to buy Canadian CDMO Biovectra in a $925 million deal, which Agilent says will deepen its focus on oligonucleotides and CRISPR. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.